Publications by authors named "Chinami Masuda"

Claim this Profile
P
PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model.
Chinami Masuda, Shinichi Onishi, Keigo Yorozu, Mitsue Kurasawa, Mamiko Morinaga

Clin Exp Metastasis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8 T cells in hematogenous metastasis model with lymphocyte infusion.
Chinami Masuda, Mamiko Morinaga, Daiko Wakita, Keigo Yorozu, Mitsue Kurasawa

Clin Exp Metastasis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.
Chinami Masuda, Masamichi Sugimoto, Daiko Wakita, Makoto Monnai, Chisako Ishimaru

Clin Exp Metastasis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
Masanobu Nishidate, Kaname Yamamoto, Chinami Masuda, Hiroaki Aikawa, Mitsuhiro Hayashi

Sci Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model.
Chinami Masuda, Mieko Yanagisawa, Keigo Yorozu, Mitsue Kurasawa, Koh Furugaki

Int J Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis